Atlas Trials

A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

Clinical trial NCT03809325 · COMPLETED

Trial details

NCT number
NCT03809325
Sponsor
Janssen-Cilag International NV
Status
COMPLETED
Study type
OBSERVATIONAL
Schizophrenia
Start date
2018-11-21
Primary completion
2019-07-12
Enrollment
225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.